Natural health product · NPN 80040259
CoQMax
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed February 22, 2013.
- Natural Product Number (NPN)
- 80040259
- Licence holder
- Xymogen
- Dosage form
- Capsule, soft
- Route
- Oral
- Licensing route
- Compendial
- First licensed
- February 22, 2013
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| 2,5-Cyclohexadiene-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl | 100 mg | Bacteria and/or yeast fermentation process |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- An antioxidant for the maintenance of good health. Helps to maintain and/or support cardiovascular health. Helps to reduce the frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic.
Non-medicinal ingredients
Palmitic acid; Safflower Oil; Linoleic acid; Medium chain triglycerides; Gelatin; Oleic acid; Glycerin